| Tag | Content |
|---|
EnhancerAtlas ID | HS062-06268 |
Organism | Homo sapiens |
Tissue/cell | GM18486 |
Coordinate | chr16:28933690-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr16 | 28934025 | 28934800 | | chr16 | 28935424 | 28935524 |
|
Enhancer Sequence | AGGTCAGGAG ATCGAGACTA TCCTGGCTAA CACGGTGAAA CCCCATCTCT ACTAAAAATA 60
CAAAAAATGG GGCCGGGCGT GGTGGGTCAC CCCTCTAATC CCAGCACTCT GGGAGGTCGA 120
GGCAGGCAGA TCACGAGGTC AGGAGATCGA GACCATCCTG GCTAACACAG TGAAACCCCG 180
TCTCTACTAA AAATTAAAAA AAAAAATTAG TCAGGCGTGG TGGCGAGCAC CTGTAGTCCC 240
AGCTGGTTGG GAGGCTGAGG CAGGAGAATA GCATGAACCC GGGAGGTGGA GCTTGCAGTA 300
AGCCAAGATC ACACCACTGT ACTCCAGCCT GGGCGACAGA GTAAGACTCC ATCTCAAAAG 360
AAAAGAAAAA AAAAATTAGC CACGTGTGGT GGCACACGCC TGTAGTCCCA GCTACTTGGG 420
AGGCTGAGGA AGGAGAATCG CTTGAACCCG GGAGGTGGAG GTTGCAGTGA GCTGAGACTG 480
CACCACTGAA CTCCAGTCTG GGTAACAGTG AGACACTGTC TCAGAAAAAA AAAAAAATAG 540
GTTCAGCTGT TAGGCTGCTT GGTTTCCAAC CTTTGGCTGT TTTCCAGCTA TATGACCTTG 600
GGCAAGTTAT TTAACCTCTC CGGGCCTCAG AGCTTCCTCT GTAAAATGGA GATGGGTAAT 660
AGTTCCTGCC TCACAGAGTT TGTTATGAAG ATTAGTTACT CATAAAGCAT TTAGCTCAGT 720
GCCTGGCACA TAGTGAGTGC TCAAAACATG CTACCTGGCC AGGCGCGGTG GCTCACACCT 780
GTAATCCCAG CACTTTGGGA GGCCAAGGCA GGCAGATCGT TTGAGCTCAG GAGTTCAAGA 840
CCTGTCTGGG TAACATAGAG AGACCCTGTT TCTACAAAAA AATACTAAAA ATTAGCCAGG 900
CATGGTGGCA TGCACCTGTA GTCTTGGCTA CTTGGGAGGC TGAGGTAGGA GGATCTGCTT 960
GAGCCCAGGA GGTGGAGGTT GCAGTGAGCT GAGATCACAC CAGCGTGCTG TGACGCACTC 1020
CAGCTTGGGC GACAGAGTGA AACTCTTATT GACTCAAGAA AAAAAAAAAA AGCTAGCTAT 1080
TGTTATTATT TAGGACACAC CTGGCTTTTC TTATATAGTA GATATAACAA GTTTCCCTTA 1140
ATAAATGTAT GTAAACTTTT AAAATGTGGA TCTATTTAAA GAACAAATAT TAAGTAAACA 1200
GCACAGTAAG TTGTACAAGG ATGTGTCTAC ATTGCACAGG CAGGTGGATC CTGAAATGTG 1260
GGAAATACAG CCCCAGAGAA GTCTCCAGCC ACCAGCAGCT GTTAGAAAGG GAAATCGCAT 1320
GTTGGGAAGG GAATTTTAGG AAGTTTACTC TGGAAGCCAA TGTCAAGGCC ACACTATAGA 1380
GGAAGATCTG TGAGAAGGTT GGGACAAAAG TCCAGGAGAG AGTTGACGAG AGCCCCACCG 1440
CAGCAGGGGC ATAGCAGCGG GGGCAGCTCT GACATCTGTT TCAGAGTCTC TGGCTTCTGC 1500
TAGAGGAAGG AGAGTAGAAA ACAGGATCAG CAGCTGGGGC GTCTGGGGCC AGAGGACCAA 1560
GTACAAAGAA CGTGGGGCGG AGGTGGGGAA GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA 1620
GTGTCTGGGG AAGGCTAGAG AGCAGAGCAT TAGACTCACA GAGACTGGGC CAGGGCTGAT 1680
TCTATTTCCC AGAAGTCCAG ACTAAAATGA GGTTGGTTTG GGGAACTGAG AAGTTTCTCG 1740
CCCATCTTCA GGGTTGATCA ATCATCAGTG AGGGACAAGA AATGACATGG GACAAGGCAA 1800
CAGATAGAAG CTGGGAGCTA AACTTAGCTA TAACTGACAG AGCTGCTGCT ATCACATGGA 1860
GGGCCTCTAT GCAAATTTTA AAAGGGCGGC CCTTCCTCTG GGCCATAGGC ATGCCCTGTG 1920
CCAGGCAGCC CTGCTAACCT ATCCCATAGC TTATCTGTGC CCCCAATCCC TTTCTCGTCA 1980
TGCACTCCCC AGTATGGGGT TGATGGGGAG TCTAGGTGAG TCCCGCGTCT 2030
|
